INTRA-CELLULAR THERAPIES INC has a total of 82 patent applications. It decreased the IP activity by 57.0%. Its first patent ever was published in 2006. It filed its patents most often in United States, Mexico and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are INTRA CELLULAR THERAPIES INC, POXEL SAS and ATOPIX THERAPEUTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 16 | |
#2 | Mexico | 9 | |
#3 | Canada | 8 | |
#4 | EPO (European Patent Office) | 8 | |
#5 | WIPO (World Intellectual Property Organization) | 8 | |
#6 | Republic of Korea | 7 | |
#7 | Japan | 6 | |
#8 | South Africa | 6 | |
#9 | Hong Kong | 4 | |
#10 | China | 3 | |
#11 | Israel | 3 | |
#12 | Brazil | 2 | |
#13 | Argentina | 1 | |
#14 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Basic materials chemistry | |
#5 | Optics | |
#6 | Agriculture |
# | Name | Total Patents |
---|---|---|
#1 | Li Peng | 57 |
#2 | Wennogle Lawrence P | 46 |
#3 | Zhao Jun | 20 |
#4 | Davis Robert | 18 |
#5 | Zheng Hailin | 15 |
#6 | Mates Sharon | 15 |
#7 | Lawrence P Wennogle | 11 |
#8 | Peng Li | 11 |
#9 | Wennogle Lawrence | 9 |
#10 | Robert Davis | 6 |
Publication | Filing date | Title |
---|---|---|
WO2020160037A1 | Novel devices | |
WO2017172784A1 | Novel salts and crystals | |
KR20170089000A | Organic compounds | |
KR20170058406A | Compounds and methods | |
US2016039829A1 | Organic compounds | |
CA2944755A1 | Organic compounds | |
US2016324860A1 | Products and pharmaceutical compositions | |
MX2016007219A | Novel methods. | |
US2015374699A1 | Phosphodiesterase-1 inhibitors and their use in treatment of cardiovascular diseases | |
MX2012012277A | Organic compounds. | |
CA2716730A1 | Substituted heterocycle fused gamma-carbolines solid |